Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a chemo drug erase ugly eye scars?

NCT ID NCT07397520

Symptom relief Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed Phase 4 trial tested whether injecting 5-fluorouracil directly into raised facial scars around the eyes could make them less noticeable. Seven adults with scars from injury or cosmetic surgery received the treatment. The study used a standard scar scale to measure changes in color, texture, and size.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
5-fluorouracil
What this could lead to
If it works, this could offer a non-surgical way to improve the appearance of raised facial scars around the eyes.
What could go wrong
This was a very small study (7 people) with no control group, so results may not apply to everyone. The treatment involves injections and may cause side effects like pain or irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

7 people

The number who actually took part.

Started

Aug 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female participants aged ≥18 years. * Presence of a facial scar in the periocular region secondary to trauma or facial cosmetic surgery. * Ability and willingness to provide written informed consent. * Signed informed consent form prior to participation. Exclusion Criteria: * Presence of active local infection in the periocular region. * Active inflammatory dermatologic or ocular disorders in the treatment area. * Known allergy or hypersensitivity to 5-fluorouracil. * Pregnancy or breastfeeding. * Inability to comply with follow-up visits. * Withdrawal of consent during the study. * Development of significant local or systemic adverse reactions during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial scarring are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facial scarring

Contacts and locations

Locations

  • Instituto de Oftalmologia F.A.P. Conde de Valenciana, I.A.P.

    Mexico City, Mexico City, 06800, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.